«AN INNOVATIVE BREAKTHROUGH IN TRANSFUSIOLOGY AND TRANSPLANTOLOGY - R&D SOLOPHARM STARTS FURTHER DEVELOPMENT OF HIGHLY EFFECTIVE SUBSTITUTE FOR DIFFERENT BLOOD TYPES THE DRUG PLASMOSOL «BLUE BLOOD»».
Read More : https://solopharm.com/about/news/6332c84a51e2b0e45abd610c
What the chain says
- Block
- 770 333
- Time
- 2022-12-15T09:20:29Z
- Signer
- 1L3ZSNuHs9hKs5HKqz1zrxSGriLxbwVSnD
- App
- twetch
- Type
- post
- Content type
- text/plain
Fields the transaction did not carry are omitted. Open the payload to see the bytes as stored.
Signed by
1L3ZSNuHs9hKs5HKqz1zrxSGriLxbwVSnD Verified